Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

MEDVi vs Zealthy

MEDVi costs $37 less a month, and both sell semaglutide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
MEDVi logo

MEDVi

7.1
★★★★☆3.6/5

Best for: knowing which pharmacy fills the vial: it names Triad Rx

Visit MEDVi →
VS
Zealthy logo

Zealthy

5.4
★★★☆☆2.7/5

Best for: coaching bundled into the price rather than sold separately

Visit Zealthy →

If you are choosing between MEDVi and Zealthy, the first difference is cost: MEDVi is $37 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. MEDVi leads our six-part score, 7.1 to 5.4. Both have drawn an FDA warning letter.

MEDVi vs Zealthy price

MEDVi is the cheaper way in: $249 a month against $286 a month at Zealthy. That is $37 less each month (13% lower), or about $444 over a year of treatment.

Drug by drug: Semaglutide is cheaper at MEDVi ($249 a month vs $286 a month).

Medications and formats

Both sell semaglutide; only Zealthy lists tirzepatide.

On format they match: each offers compounded injections.

Where each one treats patients

MEDVi lists 48 states, and Zealthy lists 34 states.

They overlap in 33 states. MEDVi alone covers 15 states, including Alaska, Delaware, Hawaii and Montana. Zealthy alone covers Mississippi.

Pricing

MEDVi

Compounded GLP-1 Injection (weekly)Compounded
$299$179/mo
Save 40% right now
semaglutide

Refills are locked in at $299. The first month is $179 in the 'SUMMER Sale,' and some MEDVi landing pages offer the first month at $149.

Compounded GLP-1 Tablets (daily dissolvable)Compounded
$249/mo
semaglutide

Flat 'Starting at $249' — no intro discount shown.

Wegovy Pill / Wegovy Injection (membership fee only; medication cost not published)Brand-name
$99/mo
semaglutide

$99 Membership + Medication Cost — medication cost not published (varies/insurance may reimburse). 'Availability is subject to change.'

Zepbound Injection (membership fee only; medication cost not published)Brand-name
$99/mo
tirzepatide

$99 Membership + Medication Cost — medication cost not published. COMPOUNDED tirzepatide ($349 in our current entry) is no longer published anywhere on glp1.medvi.org, home.medvi.org, or the intake flow (0 mentions) — treat as discontinued/not published, do not carry the $349 row forward.

Zealthy

StartingCompounded
$286/mo
semaglutide

$151 medication + $135 monthly membership

StartingCompounded
$351/mo
tirzepatide

$216 medication + $135 monthly membership

What each price covers

Both prices cover the clinician visit, shipping and coaching.

MEDVi's price also covers the medication itself, which Zealthy does not claim.

MEDVi is silent on lab work.

Zealthy is silent on the medication itself and lab work.

That matters most for the drug: unless Zealthy confirms otherwise, budget for medication on top of its listed price.

MEDVi

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

In the price

Zealthy

Covered by the monthly price

Medication

Not stated

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

In the price

Where each one scores higher

Overall, MEDVi scores 7.1 and Zealthy 5.4 out of 10.

MEDVi is stronger on user experience (8.0 vs 3.0), trust & safety (6.0 vs 3.0), accessibility (9.7 vs 7.4) and support (8.5 vs 5.5).

Value and effectiveness are within half a point.

How we score

MEDVi

7.1/10

Overall

Zealthy

5.4/10

Value25%

2.8A
vs
B
3.0

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

6.0A
vs
B
3.0

Accessibility10%

9.7A
vs
B
7.4

Support10%

8.5A
vs
B
5.5

FDA warning letters

The FDA sent MEDVi a warning letter dated February 20, 2026 (letter 721455), and it is still open.

Zealthy has 2 FDA warning letters on record.

Features & Coverage

FeatureMEDViZealthy
Starting Price✓$249/mo$286/mo
Features✓7 features3 features
States Available✓4834
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning Letters✓1 letter2 letters

About MEDVi

Two clinical groups do the treating at MEDVi: CareGLP Affiliated P.C.s, plus clinicians from OpenLoop Health. Its weight-loss menu holds compounded GLP-1s, injections and tablets alike, the molecule being semaglutide, next to Zepbound and Wegovy under their brand names. Licensed US pharmacies fill all of it.

Read our full MEDVi review →

About Zealthy

Active federal litigation and two FDA warning letters are disclosed in full; the entry exists here only for completeness, and the warnings and cons sections should be read before considering it. Zealthy sells compounded semaglutide and tirzepatide on an asynchronous telehealth model. FitRX, LLC is the legal entity, recently renamed Gronk Inc.

Read our full Zealthy review →

Pros & Cons

MEDVi

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits, shipping and coaching
  • Serves 48 states
  • Names 3 pharmacies that fill its prescriptions, which most sellers do not

Watch-outs

  • Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
  • The FDA has issued MEDVi a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Zealthy

What we like

  • The monthly price includes clinician visits, shipping and coaching

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Serves only 34 states, so check that yours is one of them
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • The FDA has issued Zealthy 2 warning letters. Read what they allege: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: MEDVi

MEDVi wins this one, 7.1 to 5.4, above all for knowing which pharmacy fills the vial: it names Triad Rx. It also costs $37 less each month than Zealthy. Zealthy fits better if coaching bundled into the price rather than sold separately is your priority.

Choose MEDVi if…

You want knowing which pharmacy fills the vial: it names Triad Rx and an opening price near $249 a month.

Choose Zealthy if…

You want coaching bundled into the price rather than sold separately and an opening price near $286 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

8.4

Collective

Flat any-dose pricing, if you can absorb a $199 annual membership on top

8.6

Found

Tirzepatide at $169/month, 37% below the typical price

7.6

Breeze Meds

Knowing which pharmacy fills the vial: it names Belmar Pharmacy

MEDVi vs Zealthy: FAQ

MEDVi. It starts at $249 a month; Zealthy starts at $286 a month, $37 more per month.
Yes, both sell semaglutide. Zealthy adds tirzepatide.
MEDVi: 48 states against 34, with 33 in common.
Both include the clinician visit, shipping and coaching. Only MEDVi includes the medication itself.
MEDVi has an open FDA warning letter from February 20, 2026. Zealthy has 2 FDA warning letters on record.
No. Neither MEDVi nor Zealthy pays us anything.

Or see the full category ranking.